Skip to content

Brain-computer interfaces

Early commercialmomentum 24994 papers in 3 months (-12% yearly)$743M raised in 12 months19 companies

Devices that read or stimulate brain signals so a person can control a computer, speak or see without using muscles.

Why early commercial: Science Corp. launched PRIMA commercially in Europe after a CE mark, the first BCI cleared there for form vision restoration. Jul 22, 2026

Papers per monthOpenAlex journal and conference papers; January includes papers dated by year only; the last two months are still filling in
07681.5kSep 24Mar 25Sep 25Mar 26

Dots under a month: dated events tracked here that month.

30 events

DateEvent
Aug 2026
Aug 31CorTec gets second FDA breakthrough designationcortec-neuro.com· Announcement
Jul 2026
Jul 27NeuroXess BCI enters China's innovative device review trackneuroxess.com· Policy
Jul 22PRIMA launches commercially in Europe with a CE markscience.xyz· Product
Jun 2026
Jun 17Paradromics performs first implant in Connect-One trialparadromics.com· Milestone
Apr 2026
Apr 28FDA clears Motif's depression BCI for a first clinical trialnews.rice.edu· Policy
Jan 2026
Jan 28Neuralink reports 21 trial participantsneuralink.com· Milestone
Jan 15Merge Labs launchesmerge.io· Announcement
Jan 12Precision and Medtronic partner on BCI integrationglobenewswire.com· Deal
Nov 2025
Nov 20FDA approves Paradromics Connect-One studyparadromics.com· Policy
Nov 5UNESCO adopts first global standard on neurotechnology ethicsunesco.org· Policy
Oct 2025
Oct 20NEJM reports PRIMA restores central vision in macular degenerationscience.xyz· Breakthrough
Oct 2Precision shows high-bandwidth BCI without open surgeryprecisionneuro.io· Breakthrough
Aug 2025
Aug 14Inner speech decoded from motor cortexdoi.org· Breakthrough
Jul 2025
Jul 31Neuralink launches GB-PRIME study in Great Britainneuralink.com· Announcement
Jul 23Meta publishes a generic wrist EMG interfacedoi.org· Breakthrough
Jun 2025
Jun 12Instantaneous voice synthesis from brain signalsdoi.org· Breakthrough
Jun 2Paradromics completes first-in-human recording with Connexusparadromics.com· Milestone
May 2025
May 13Apple adds a BCI protocol to iOS, iPadOS and visionOSapple.com· Product
May 1Neuralink speech restoration gets FDA breakthrough designationneuralink.com· Announcement
Apr 2025
Apr 17Precision gets FDA 510(k) clearance for Layer 7 arrayprecisionneuro.io· Product
Mar 2025
Mar 31Streaming brain-to-voice neuroprosthesisdoi.org· Breakthrough
Nov 2024
Nov 24Neuralink launches CONVOY robotic arm studyneuralink.com· Announcement
Nov 20Health Canada approves Neuralink's CAN-PRIME trialneuralink.com· Policy
Oct 2024
Oct 21PRIMA pivotal trial shows preliminary vision gainsscience.xyz· Milestone
Sep 2024
Sep 30Synchron reports positive results from its US COMMAND studysynchron.com· Milestone
Sep 17Neuralink's Blindsight gets FDA breakthrough device designationneuralink.com· Announcement
Aug 2024
Aug 15Speech neuroprosthesis reaches high accuracy within daysdoi.org· Breakthrough
May 2024
May 20Bilingual speech neuroprosthesis decodes Spanish and Englishdoi.org· Breakthrough
Apr 2024
Apr 25Science Corp. agrees to acquire Pixium Vision's PRIMA assetsscience.xyz· Deal
Apr 12Neuralink reports on its first human implantneuralink.com· Milestone
About brain-computer interfaces here
Sub-areas
Intracortical implants, Endovascular implants, Surface cortical arrays, Speech neuroprostheses, Visual prostheses, Therapeutic neuromodulation BCIs, Non-invasive EEG and EMG interfaces
Stage evidence
Early commercial, Jul 22, 2026: Science Corp. launched PRIMA commercially in Europe after a CE mark, the first BCI cleared there for form vision restoration. science.xyz
Momentum
24 of 100: the mean of its ranks among the tracked fields for paper growth (19), funding in 12 months (19) and events in 90 days (34). Method
Papers
6,580 in the 12 months ending two months ago, -12% against the 12 before (OpenAlex topics, journal and conference papers).
Tracked here since
Sep 25, 2026

Frontier tech by email

Tuesdays, only in weeks with new milestones, rounds or stage changes in the fields tracked here.

Double opt-in. Unsubscribe any time.